Impact of using triclosan-impregnated sutures on incidence of surgical site infection: a real world Indian study

Shivpreet Singh Samra; Vijay Jagad; Munish Mahajan; M. S. Randhawa; Chetna Trehan

doi:10.18203/2349-2902.isj20180369

Authors

Shivpreet Singh Samra Department of Cardiothoracic Surgery, Grecian Hospital, Mohali, Punjab, India
Vijay Jagad Department of Oncology, Grecian Hospital, Mohali, Punjab, India
Munish Mahajan Department of Oncology, Grecian Hospital, Mohali, Punjab, India
M. S. Randhawa Department of Urology, Grecian Hospital, Mohali, Punjab, India
Chetna Trehan Department of Gynaecology, Grecian Hospital, Mohali, Punjab, India

DOI:

https://doi.org/10.18203/2349-2902.isj20180369

Keywords:

Antibiotic-coated sutures, Clean wound, Nosocomial infections, Surgical Site Infection (SSI), Surgical Asepsis, Triclosan-coated sutures, Wound infection

Abstract

Background: Surgical Site Infection is an index of health care system of any hospital. Surgical material is a risk factor for SSI that can be easily changed. One of such measures is the use of antimicrobial suture technology which involves the impregnation of synthetic, absorbable, polymeric sutures with the antiseptic, Triclosan. Triclosan-coated sutures inhibit bacterial colonization of wide-spectrum of pathogens. This study was designed to assess the efficacy of triclosan coated sutures in reducing incidence of surgical site infection in Indian population.

Methods: This is a retrospective ‘real-world’ study of 150 patients who underwent surgery and wound closure with triclosan-coated suture from May 2015 to December 2015 at Grecian Hospital, Mohali. Incidence of SSI was recorded, and nature of wound was categorized. Data was subject to descriptive analysis.

Results: A 99.3% of wounds sutured with triclosan coated sutures did not have surgical site infection. The single case of SSI encountered was categorized as superficial-incisional. All the evaluated cases were categorized as ‘clean’ at the time of discharge.

Conclusions: Triclosan-coated sutures were responsible for the reported reduction in SSI, particularly in adult patients with clean wounds. This study justifies that in addition to the mandated core measures of surgical care, adjunctive evidence-based interventions such as Triclosan-coated sutures should be considered in the comprehensive effort to decrease risk of surgical site infection and improve outcome at both patient and institutional levels.

Metrics

Metrics Loading ...

References

Zhan C, Miller MR. Excess length of stay, charges, and mortality attributable to medical injuries during hospitalization. JAMA. 2003;290:1868-74.

Horan TC, Gaynes RP, Martone WJ. CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. Infect Control Hosp Epidemiol. 1992;13:606-8.

Leaper DJ, van Goor H, Reilly J, Petrosillo N, Geiss HK, Torres AJ. Surgical site infection- a European perspective of incidence and economic burden. Int Wound J. 2004;1:247-73.

Brown S, Kurtsikahvi G, Alonso EJ, Aha L, Bochoidez T, Shushtakashiri M, et al. Prevalence and predictors of SSI in Tbilisi Republic of Georgia. J Hosp Infect. 2007;66:160-6.

Tripathy BS, Roy N. Post-operative wound sepsis. Indian J Surg. 1984;47:285-8.

Abbey RK, Mohan M, Malik N, Tiwari R, Nahar S. Surgical Site Infections in a Rural Teaching Hospital of North India. Int J Adv Integ Med Sci 2017;2(1):11-6.

Odom-Forren J. Preventing surgical site infections. Nursing. 2006;36:58-63.

Rouzier R, Pusztai L, Delaloge S. Nomograms to predict pathologic complete response and metastasis-free survival after preoperative chemotherapy for breast cancer. J Clin Oncol. 2005;23(33):8331-9.

Varma S, Ferguson HC, Breen DV, Lumb WV. Comparison of seven suture materials in infected wounds: an experimental study. J Surg Res. 1974;17:165-70.

Allegranzi B, Bischoff P, de Jonge S. New WHO recommendations on preoperative measures for surgical site infection prevention: an evidence-based global perspective. Lancet Infect Dis. 2016;2(6):3099.

Berríos-Torres SI, Umscheid CA, Bratzler DW, Leas B, Stone EC, Kelz RR, et al. Centers for Disease Control and Prevention guideline for the prevention of surgical site infection, 2017. JAMA Surg. 2017.

Barbolt TA. Chemistry and safety of triclosan, and its use as an antimicrobial coating on coated VICRYL plus antibacterial suture (coated polyglactin 910 suture with triclosan) Surgical Infections. 2002;3:S45-53.

McMurry LM, Oethinger M, Levy SB. Triclosan targets lipid synthesis. Nature. 1998;394:531-2.

Edmiston CE, Patkar AD, Magee G, Seabrook GR, Vaughn B. Use of an observational, nationwide inpatient discharge database to document the economic benefits associated with innovative antimicrobial technology to reduce the risk of surgical site infection (SSI). Am J Infect Control. 2010;38:E38.

Fleck T, Moidl R, Blacky A, Fleck M, Wolner E, Grabenwoger M et al. Triclosan-coated sutures for the reduction of sternal wound infections: economic considerations. Ann Thorac Surg. 2007;84:232-6.

Leaper DJ, Edmiston CE Jr, Holy CE. Meta-analysis of the potential economic impact following introduction of absorbable antimicrobial sutures. Br J Surg. 2017;104(2):e134-44.

Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR. Guideline for Prevention of Surgical Site Infection, 1999. Centers for Disease Control and Prevention (CDC) Hospital Infection Control Practice Advisory Committee. Am J Infect Control. 1999;27(2):97-132.

Engemann JJ, Carmeli Y, Cosgrove SE, Fowler VG, Bronstein MZ, Trivette SL, et al. Adverse and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureussurgical site infection. Clin Infect Dis. 2003;36(5):592-8.

Edlich RF, Panek PH, Rodeheaver GT, Turenbull VG, Kurtz LD, Edgerton MT. Physical and chemical configuration of sutures in the development of surgical infection. Ann Surg. 1973;177(6):679-88.

Center for Disease Control. National Nosocomial Infections Study Quarterly Report, First and Second Quarters. Altlanta: CDC, 1973.

Nichols RL. Preventing surgical site infections. Clin Med Res. 2004;2:115-8.

Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR. Guideline for Prevention of Surgical Site Infection, 1999. Centers for Disease Control and Prevention (CDC) Hospital Infection Control Practices Advisory Committee. Am J Infect Control. 1999;27:97-132.

Slater-Radosti C, Van Aller G, Greenwood R, Nicholas R, Keller PM, DeWolf WE, et al. Biochemical and genetic characterization of the action of triclosan on Staphylococcus aureus. J Antimicrob Chemother. 2001;48(1):1-6.

Leaper D, Assadian O, Hubner NO, McBain A, Barbolt T, Rothenburger S, et al. Antimicrobial sutures and prevention of surgical site infection: assessment of the safety of the antiseptic triclosan. Int Wound J. 2011;8:556-66.

Galal I, El-Hindawy K. Impact of using triclosan-antibacterial sutures on incidence of surgical site infection. Am J Surg. 2011;202(2):133-8.

Rozzelle CJ, Leonardo J, Li V. Antimicrobial suture wound closure for cerebrospinal fluid surgery: a prospective, double-blinded, randomized controlled trial. J Neurosurg Pediatr. 2008;2(2):111-7.

Daoud FC, Edmiston CE Jr, Leaper D. Meta-analysis of prevention of surgical site infections following incision closure with triclosan-coated sutures: robustness to new evidence. Surg Infect. 2014;15:165.

Justinger C, Schuld J, Sperling J, Kollmar O, Richter S, Schilling MK. Triclosan-coated sutures reduce wound infections after hepatobiliary surgeryda prospective nonrandomized clinical pathway driven study. Langenbecks Arch Surg. 2011;396:845.